Cliona M Rooney

10PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 01, 2025
Tunneling CARs: Increasing CAR T-Cell Tumor Infiltration through the Overexpression of MMP-7 and Osteopontin-b.

Stacey Van Pelt, Mark White, Candise Tat

|Jul 24, 2025
Constitutive IL-7 signaling promotes CAR-NK cell survival in the solid tumor microenvironment but impairs tumor control.

Matthew Dysthe, Ishwar Navin, Dayenne van Leeuwen

|Feb 05, 2025
Differential antibody response to EBV proteome following EBVST immunotherapy in EBV-associated lymphomas.

Yomani D Sarathkumara, Nathan W Van Bibber, Zhiwei Liu

|May 21, 2024
Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors.

Frank Y Lin, Austin Stuckert, Candise Tat

|Apr 19, 2024
Cotargeting EBV lytic as well as latent cycle antigens increases T-cell potency against lymphoma.

Sandhya Sharma, Naren U Mehta, Tim Sauer

|Apr 18, 2023
Naive T cells inhibit the outgrowth of intractable antigen-activated memory T cells: implications for T-cell immunotherapy.

Sandhya Sharma, Mae Woods, Naren U Mehta

Pageof 2